These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26051589)

  • 21. Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity.
    Renn JP; Doritchamou JYA; Tentokam BCN; Morrison RD; Cowles MV; Burkhardt M; Ma R; Mahamar A; Attaher O; Diarra BS; Traore M; Dicko A; Tolia NH; Fried M; Duffy PE
    Commun Biol; 2021 Nov; 4(1):1309. PubMed ID: 34799664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placental malaria vaccine candidate antigen VAR2CSA displays atypical domain architecture in some
    Doritchamou JYA; Morrison R; Renn JP; Ribeiro J; Duan J; Fried M; Duffy PE
    Commun Biol; 2019; 2():457. PubMed ID: 31840102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pregnancy-associated malaria: parasite binding, natural immunity and vaccine development.
    Gamain B; Smith JD; Viebig NK; Gysin J; Scherf A
    Int J Parasitol; 2007 Mar; 37(3-4):273-83. PubMed ID: 17224156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural and immunological correlations between the variable blocks of the VAR2CSA domain DBL6ε from two Plasmodium falciparum parasite lines.
    Gangnard S; Badaut C; Ramboarina S; Baron B; Ramdani T; Gamain B; Deloron P; Lewit-Bentley A; Bentley GA
    J Mol Biol; 2013 May; 425(10):1697-711. PubMed ID: 23429057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VAR2CSA Domain-Specific Analysis of Naturally Acquired Functional Antibodies to Plasmodium falciparum Placental Malaria.
    Doritchamou JY; Herrera R; Aebig JA; Morrison R; Nguyen V; Reiter K; Shimp RL; MacDonald NJ; Narum DL; Fried M; Duffy PE
    J Infect Dis; 2016 Aug; 214(4):577-86. PubMed ID: 27190180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mother-Newborn Pairs in Malawi Have Similar Antibody Repertoires to Diverse Malaria Antigens.
    Boudová S; Walldorf JA; Bailey JA; Divala T; Mungwira R; Mawindo P; Pablo J; Jasinskas A; Nakajima R; Ouattara A; Adams M; Felgner PL; Plowe CV; Travassos MA; Laufer MK
    Clin Vaccine Immunol; 2017 Oct; 24(10):. PubMed ID: 28835359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of functional assays used in the clinical development of a placental malaria vaccine.
    Pehrson C; Heno KK; Adams Y; Resende M; Mathiesen L; Soegaard M; de Jongh WA; Theander TG; Salanti A; Nielsen MA
    Vaccine; 2017 Jan; 35(4):610-618. PubMed ID: 28012775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-Throughput Testing of Antibody-Dependent Binding Inhibition of Placental Malaria Parasites.
    Nielsen MA; Salanti A
    Methods Mol Biol; 2015; 1325():241-53. PubMed ID: 26450394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Of mice and women: rodent models of placental malaria.
    Hviid L; Marinho CR; Staalsoe T; Penha-Gonçalves C
    Trends Parasitol; 2010 Aug; 26(8):412-9. PubMed ID: 20605743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA.
    Doritchamou J; Nielsen MA; Chêne A; Viebig NK; Lambert LE; Sander AF; Semblat JP; Hundt S; Orr-Gonzalez S; Janitzek CM; Spiegel AJ; Clemmensen SB; Thomas ML; Nason MC; Snow-Smith M; Barnafo EK; Shiloach J; Chen BB; Nadakal S; Highsmith K; Ouahes T; Conteh S; Sharma A; Torano H; Butler B; Reiter K; Rausch KM; Scaria PV; Anderson C; Narum DL; Salanti A; Fried M; Theander TG; Gamain B; Duffy PE
    Lab Anim (NY); 2023 Dec; 52(12):315-323. PubMed ID: 37932470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization with recombinant duffy binding-like-gamma3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate A-binding Plasmodium falciparum parasites.
    Costa FT; Fusaï T; Parzy D; Sterkers Y; Torrentino M; Douki JB; Traoré B; Petres S; Scherf A; Gysin J
    J Infect Dis; 2003 Jul; 188(1):153-64. PubMed ID: 12825185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential adhesion-inhibitory patterns of antibodies raised against two major variants of the NTS-DBL2X region of VAR2CSA.
    Doritchamou J; Bigey P; Nielsen MA; Gnidehou S; Ezinmegnon S; Burgain A; Massougbodji A; Deloron P; Salanti A; Ndam NT
    Vaccine; 2013 Sep; 31(41):4516-22. PubMed ID: 23933341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High efficacy of anti DBL4ɛ-VAR2CSA antibodies in inhibition of CSA-binding Plasmodium falciparum-infected erythrocytes from pregnant women.
    Magistrado PA; Minja D; Doritchamou J; Ndam NT; John D; Schmiegelow C; Massougbodji A; Dahlbäck M; Ditlev SB; Pinto VV; Resende M; Lusingu J; Theander TG; Salanti A; Nielsen MA
    Vaccine; 2011 Jan; 29(3):437-43. PubMed ID: 21075162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VAR2CSA and protective immunity against pregnancy-associated Plasmodium falciparum malaria.
    Hviid L; Salanti A
    Parasitology; 2007; 134(Pt 13):1871-6. PubMed ID: 17958922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional genomic technologies applied to the control of the human malaria parasite, Plasmodium falciparum.
    Carucci DJ
    Pharmacogenomics; 2001 May; 2(2):137-42. PubMed ID: 11368752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical immunogenicity and safety of the cGMP-grade placental malaria vaccine PRIMVAC.
    Chêne A; Gangnard S; Guadall A; Ginisty H; Leroy O; Havelange N; Viebig NK; Gamain B
    EBioMedicine; 2019 Apr; 42():145-156. PubMed ID: 30885725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of transgenic parasites in malaria vaccine research.
    Othman AS; Marin-Mogollon C; Salman AM; Franke-Fayard BM; Janse CJ; Khan SM
    Expert Rev Vaccines; 2017 Jul; 16(7):1-13. PubMed ID: 28525963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved pregnancy outcomes in women exposed to malaria with high antibody levels against Plasmodium falciparum.
    Mayor A; Kumar U; Bardají A; Gupta P; Jiménez A; Hamad A; Sigaúque B; Singh B; Quintó L; Kumar S; Gupta PK; Chauhan VS; Dobaño C; Alonso PL; Menéndez C; Chitnis CE
    J Infect Dis; 2013 Jun; 207(11):1664-74. PubMed ID: 23448726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased susceptibility to Plasmodium falciparum infection in pregnant women with iron deficiency.
    Kabyemela ER; Fried M; Kurtis JD; Mutabingwa TK; Duffy PE
    J Infect Dis; 2008 Jul; 198(2):163-6. PubMed ID: 18500927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High level of var2csa transcription by Plasmodium falciparum isolated from the placenta.
    Tuikue Ndam NG; Salanti A; Bertin G; Dahlbäck M; Fievet N; Turner L; Gaye A; Theander T; Deloron P
    J Infect Dis; 2005 Jul; 192(2):331-5. PubMed ID: 15962229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.